Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds
November 14, 2024 16:15 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative...
Westmount Capital Partners Retained as Financial Advisor for Ozone Story Tech
September 30, 2024 21:00 ET
|
Westmount Capital Partners Inc.
Westmount Capital Partners is raising $10M in equity for Ozone Story Tech to support AI-driven animation technology, with Robin Riley joining as new CEO
Azerion raises €10.5 million in equity
July 15, 2022 01:45 ET
|
Azerion Group NV
Amsterdam, 15 July 2022 - Azerion today announces a small equity capital raise of €10.5 million in the form of a private placement of existing ordinary treasury shares of Azerion, predominantly to...
CHF Solutions, Inc. Announces Closing of $20.9 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option
March 19, 2021 12:04 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., March 19, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) (the “Company”) today announced the closing of its previously announced underwritten public offering of...
CHF Solutions, Inc. Announces Proposed Underwritten Public Offering of Common Stock
March 16, 2021 16:05 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., March 16, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) (the “Company”) announced today that it intends to offer shares of its common stock in an underwritten...
Cyclacel Pharmaceuticals Prices $12.65 Million Underwritten Public Offering of Common Stock
March 12, 2021 08:30 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., March 12, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing...
Cyclacel Pharmaceuticals Announces Proposed Public Offering of Common Stock
March 11, 2021 16:01 ET
|
Cyclacel
BERKELEY HEIGHTS, N.J., March 11, 2021 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing...
CHF Solutions, Inc. Announces Pricing of $12.5 Million Underwritten Public Offering
August 19, 2020 08:30 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Aug. 19, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today...
CHF Solutions, Inc. Announces Closing of $9.66 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
January 28, 2020 16:10 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Jan. 28, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) today announced the closing of an underwritten public offering of units for gross proceeds of approximately...
CHF Solutions, Inc. Announces Pricing of $8.4 Million Underwritten Public Offering
January 24, 2020 09:37 ET
|
CHF Solutions, Inc.
EDEN PRAIRIE, Minn., Jan. 24, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ:CHFS) today announced the pricing of an underwritten public offering of units for gross proceeds of approximately...